Prothena Corporation plc (PRTA) support and resistance · rev $1.0M
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
This page maps Prothena Corporation plc (PRTA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PRTA revenue for 2026-06-30 was $1.0M. Net income was -$18.6M. Revenue was down 98.0% from 2026-03-31 to 2026-06-30. PRTA currently screens at market cap $460.2M.
PRTA currently screens at market cap $460.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PRTA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PRTA quote page for the session range and the stock page for the full model.
Not investment advice.